Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Eidos Therapeutics Inc (EIDX)

Eidos Therapeutics Inc (EIDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer

Biomea Fusion, Inc. ("Biomea") (Nasdaq: BMEA), a preclinical-stage biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically...

FSNN : 0.0580 (-19.44%)
BMEA : 13.22 (-0.23%)
EIDX : 122.21 (-4.85%)
BBIO : 55.37 (+3.03%)
IOVA : 22.92 (+4.99%)
BridgeBio Pharma, Inc. Reports Fourth Quarter And Full Year 2020 Financial Results And Business Update

-Completed acquisition of Eidos Therapeutics, allowing BridgeBio to deploy its full clinical and commercial infrastructure to develop and plan for potential global commercialization upon regulatory approval...

BBIO : 55.37 (+3.03%)
EIDX : 122.21 (-4.85%)
BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.

BridgeBio Pharma, Inc. ("BridgeBio") (Nasdaq: BBIO) today announced that it has completed its acquisition of all of the outstanding shares of Eidos Therapeutics, Inc. ("Eidos") (formerly Nasdaq: EIDX)...

BBIO : 55.37 (+3.03%)
EIDX : 122.21 (-4.85%)
Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.

BridgeBio Pharma, Inc. ("BridgeBio") (Nasdaq: BBIO) and Eidos Therapeutics, Inc. ("Eidos") (Nasdaq: EIDX) today announced that the stockholders of each of BridgeBio and Eidos voted to approve all proposals...

BBIO : 55.37 (+3.03%)
EIDX : 122.21 (-4.85%)
BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for Merger

BridgeBio Pharma, Inc. ("BridgeBio") (Nasdaq: BBIO) and Eidos Therapeutics, Inc. ("Eidos") (Nasdaq: EIDX) announced today that the acquisition of shares of common stock of Eidos not held by BridgeBio or...

BBIO : 55.37 (+3.03%)
EIDX : 122.21 (-4.85%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, IPHI, ALXN, and XLNX Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

EIDX : 122.21 (-4.85%)
IPHI : 172.27 (-1.08%)
ALXN : 182.50 (+1.70%)
XLNX : 138.54 (+5.76%)
ALERT: Halper Sadeh LLP Investigates ALXN, SPWH, CBMG, STND, EIDX; Shareholders Are Encouraged to Contact the Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

ALXN : 182.50 (+1.70%)
SPWH : 17.63 (-0.62%)
CBMG : 19.75 (unch)
STND : 33.00 (+0.06%)
EIDX : 122.21 (-4.85%)
EIDOS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of EIDX and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Eidos Therapeutics, Inc. (NASDAQ: EIDX) breached their...

EIDX : 122.21 (-4.85%)
BBIO : 55.37 (+3.03%)
Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote "FOR" Proposed Merger

BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced that leading proxy advisory firm Institutional Shareholder Services ("ISS") recommends that BridgeBio stockholders and Eidos Therapeutics, Inc. (Nasdaq:...

BBIO : 55.37 (+3.03%)
EIDX : 122.21 (-4.85%)
Lifshitz Law Firm, P.C. Announces Investigation of EIDX, NAV, STND, and WTRE

NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Lifshitz Law Firm, P.C.:

EIDX : 122.21 (-4.85%)
NAV : 44.50 (+0.16%)
STND : 33.00 (+0.06%)
WTRE : 34.99 (unch)
WeissLaw LLP Reminds MTSC, EIDX, IPHI, and ALXN Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

MTSC : 58.49 (-0.02%)
EIDX : 122.21 (-4.85%)
IPHI : 172.27 (-1.08%)
ALXN : 182.50 (+1.70%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers - CKH, WDR, NAV, EIDX

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CKH : 41.50 (+0.22%)
WDR : 24.98 (-0.04%)
NAV : 44.50 (+0.16%)
EIDX : 122.21 (-4.85%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - PRGX, STND, NK, EIDX, ARA

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

PRGX : 7.71 (+0.13%)
STND : 33.00 (+0.06%)
NK : 32.49 (+14.89%)
EIDX : 122.21 (-4.85%)
ARA : 11.52 (+0.17%)
Lifshitz Law Firm, P.C. Announces Investigation of EIDX, NAV, STND, and WTRE

NEW YORK, NY / ACCESSWIRE / December 26, 2020 / Lifshitz Law Firm, P.C.:

EIDX : 122.21 (-4.85%)
NAV : 44.50 (+0.16%)
STND : 33.00 (+0.06%)
WTRE : 34.99 (unch)
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers - STND, EIDX, ARA, RESI

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

STND : 33.00 (+0.06%)
EIDX : 122.21 (-4.85%)
ARA : 11.52 (+0.17%)
RESI : 16.23 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - STND, EIDX, WTRE, ARA, CGIX

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

STND : 33.00 (+0.06%)
EIDX : 122.21 (-4.85%)
WTRE : 34.99 (unch)
ARA : 11.52 (+0.17%)
CGIX : 4.61 (-2.33%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds DMYD, EIDX, IPHI, and MCAC Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

DMYD : 16.21 (-11.23%)
EIDX : 122.21 (-4.85%)
IPHI : 172.27 (-1.08%)
MCAC : 13.34 (-0.82%)
Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, EIDX, CIT, EMIS, FCNCA, FCNCB, EV, MS, NAV, STND, and WTRE

, /PRNewswire/ --  

EIDX : 122.21 (-4.85%)
FCNCA : 790.88 (+1.50%)
ARA : 11.52 (+0.17%)
BBIO : 55.37 (+3.03%)
CIT : 48.72 (+0.89%)
EV : 73.07 (-0.98%)
MS : 96.07 (-0.42%)
EMIS : 7.8100 (+0.13%)
NAV : 44.50 (+0.16%)
STND : 33.00 (+0.06%)
WTRE : 34.99 (unch)
STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

, /PRNewswire/ -- , founder and managing partner at , a national securities firm headquartered at the in , is investigating:

RESI.LN : 104.500 (+1.46%)
EIDX : 122.21 (-4.85%)
WTRE : 34.99 (unch)
XLNX : 138.54 (+5.76%)
INFO : 112.32 (-0.85%)
RESI : 16.23 (unch)
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm - CBMG, MVC, STND, EIDX

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CBMG : 19.75 (unch)
MVC : 9.12 (+2.59%)
STND : 33.00 (+0.06%)
EIDX : 122.21 (-4.85%)

Barchart Exclusives

The US Dollar Index Rallies- The Greenback Could Have Hit A Wall
After consolidating around the 90 level from mid-May to mid-June, the dollar index moved higher. While the short-term price action remains bullish, the medium-term remains bearish, which could mean the dollar is near a technical brick wall. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar